Home » Topics » BioWorld Science

BioWorld Science
RSS

Research on IL-38 mRNA expression in cancers supports Immunome's development of IMM-ONC-01

May 24, 2022

Anti-IL13RA1 eblasakimab reduces neuronal response to proinflammatory cytokines

May 24, 2022

PharmaCyte studies pancreatic cancer therapy to treat malignant ascites

May 24, 2022

Aptamer and PinotBio extend collaboration to develop Optimer-drug conjugates

May 24, 2022

KaliVir and Roche to collaborate on novel oncolytic vaccinia viruses

May 24, 2022

FDA grants orphan drug designation to DepYmed's DPM-1001 for Wilson disease

May 24, 2022

Salubris submits CTA in Europe for CTLA-4/IL-15 antibody fusion protein JK-08

May 24, 2022

AKAP11 is a risk gene shared by bipolar disorder and schizophrenia

May 24, 2022

Entrada's EEV treatments progress for Duchenne muscular dystrophy, myotonic dystrophy type 1

May 24, 2022

New c-Myc inhibitors presented by Suzhou Kintor Pharmaceuticals

May 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...